Quality-of-life impact of sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients.
暂无分享,去创建一个
O. Garin | A. Pont | Ferran Escalada | Roser Belmonte | R. Belmonte | F. Escalada | Olatz Garin | Marcel Segura | Angels Pont | Montserrat Ferrer | M. Segura | Montserrat Ferrer
[1] P. Del Bianco,et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. , 2008, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[2] Isl Isl,et al. The diagnosis and treatment of peripheral lymphedema. , 2009, Lymphology.
[3] P. Christiansen,et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. , 2008, Breast.
[4] D. Rew. The challenges of success. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[5] E. Regidor,et al. [Population reference values of the Spanish version of the Health Questionnaire SF-36]. , 1998, Medicina clinica.
[6] W. Kwan,et al. Chronic arm morbidity after curative breast cancer treatment: prevalence and impact on quality of life. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] N. Taira,et al. Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery. , 2009, Japanese journal of clinical oncology.
[8] H. Brenner,et al. Quality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based study , 2008, Journal of Cancer Research and Clinical Oncology.
[9] U. Chetty,et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.
[10] Sheryl G. A. Gabram,et al. Surgical Complications Associated With Sentinel Lymph Node Biopsy: Results From a Prospective International Cooperative Group Trial , 2006, Annals of Surgical Oncology.
[11] L. Fallowfield,et al. The validation of a quality of life scale to assess the impact of arm morbidity in breast cancer patients post-operatively , 2001, Breast Cancer Research and Treatment.
[12] L. Fallowfield. Evolution of breast cancer treatments: current options and quality-of-life considerations. , 2004, European journal of oncology nursing : the official journal of European Oncology Nursing Society.
[13] DeAnn Lazovich,et al. Lymphedema and quality of life in breast cancer survivors: the Iowa Women's Health Study. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] Andreas Shamiyeh,et al. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma , 2000, Cancer.
[15] D. Neuberg,et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. , 2004, Journal of clinical epidemiology.
[16] Isl Isl,et al. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. , 2013, Lymphology.
[17] R. B. Martínez,et al. Validación de la versión española del Functional Assessment of Cancer Therapy Questionnaire for Breast Cancer (FACT-B+4) , 2011 .
[18] L. Prieto,et al. Valores poblacionales de referencia de la versión española del Cuestionario de Salud SF-36 , 1998 .
[19] E. Wight,et al. Morbidity of Sentinel Lymph Node Biopsy (SLN) Alone Versus SLN and Completion Axillary Lymph Node Dissection After Breast Cancer Surgery: A Prospective Swiss Multicenter Study on 659 Patients , 2007, Annals of surgery.
[20] J. Ferlay,et al. Estimates of the cancer incidence and mortality in Europe in 2006. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[21] D S Tulsky,et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] H. Hoekstra,et al. A Longitudinal Comparison of Arm Morbidity in Stage I–II Breast Cancer Patients Treated with Sentinel Lymph Node Biopsy, Sentinel Lymph Node Biopsy Followed by Completion Lymph Node Dissection, or Axillary Lymph Node Dissection , 2010, Annals of Surgical Oncology.
[23] Byeong‐Woo Park,et al. Quality of Life Differences between Younger and Older Breast Cancer Patients , 2011, Journal of breast cancer.
[24] A. Giuliano,et al. Long-Term Morbidity of Sentinel Node Biopsy Versus Complete Axillary Dissection for Unilateral Breast Cancer , 2008, Annals of Surgical Oncology.
[25] F. Peintinger,et al. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients , 2003, British Journal of Cancer.
[26] Lewis E. Kazis,et al. Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.
[27] A. Giuliano,et al. Improved Axillary Staging of Breast Cancer with Sentinel Lymphadenectomy , 1995, Annals of surgery.
[28] T. Dimpfl,et al. Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer—Long-Term Follow-Up of a Matched-Pair Analysis , 2001, Annals of Surgical Oncology.
[29] O. Garin,et al. [Interpretation of SF-36 and SF-12 questionnaires in Spain: physical and mental components]. , 2008, Medicina clinica.
[30] Surgical guidelines for the management of breast cancer. , 2009, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[31] John Boyages,et al. Reliability and validity of arm volume measurements for assessment of lymphedema. , 2006, Physical therapy.
[32] E. Winer,et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] S. Duffy,et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] R. Newcombe,et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer , 2006, Breast Cancer Research and Treatment.
[35] Gemma Vilagut,et al. Interpretación de los cuestionarios de salud SF-36 y SF-12 en España: componentes físico y mental , 2008 .
[36] Monica Morrow,et al. Locoregional treatment of primary breast cancer , 2010, Cancer.
[37] Harald J. Hoekstra,et al. Quality of Life After Sentinel Lymph Node Biopsy or Axillary Lymph Node Dissection in Stage I/II Breast Cancer Patients: A Prospective Longitudinal Study , 2008, Annals of Surgical Oncology.
[38] L. Pusztai,et al. Use of standard markers and incorporation of molecular markers into breast cancer therapy , 2011, Cancer.
[39] José Antonio Bello Pereira,et al. Impacto de la disponibilidad de un servicio externo de medicina nuclear en la aplicación de la biopsia del ganglio centinela en cirugía del cáncer de mama , 2006 .
[40] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 2008. , 2010, European journal of cancer.
[41] M. Kurosumi,et al. Current trends of sentinel lymph node biopsy for breast cancer —A surgeon’s perspective , 2007, Breast cancer.